Dorimon, Michael Rolly T.
HRN: 02-39-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2025
CEFTRIAXONE 1G (VIAL)
08/27/2025
09/03/2025
IV
2G
OD
Multiple Physical Injuries
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines